MAIA Biotechnology, Inc. (MAIA)

Stammdaten

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Unternehmen & Branche

Name	MAIA Biotechnology, Inc.
Ticker	MAIA
CIK	0001878313
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock
Marktkapitalisierung	50,5 Mio. USD
Beta	0,32
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K		-22,396,172	-0.70	9,704,656	2,375,863
2025-09-30	10-Q		-8,903,189	-0.27	11,782,021	41,670
2025-06-30	10-Q		-5,346,963	-0.18	11,045,854	3,876,684
2025-03-31	10-Q		-4,517,259	-0.16	11,864,652	4,942,525
2024-12-31	10-K	0	-23,254,656	-1.05	10,155,279	3,634,636
2024-09-30	10-Q		-2,735,987	-0.11	9,242,842	1,618,591
2024-06-30	10-Q		-8,879,276	-0.40	12,019,608	3,161,895
2024-03-31	10-Q		-8,067,455	-0.46	8,716,036	-5,764,928
2023-12-31	10-K	0		-1.49	7,566,852	477,511
2022-12-31	10-K	0		-1.75	12,022,040
2022-09-30	10-Q	0		-0.48	14,782,665
2022-06-30	10-Q	0	-3,305,883	-0.40	9,759,654
2021-06-30	10-Q		-3,430,714	-0.78

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2025-12-22	Smith Stan	Director	Open Market Purchase	57,189	1.22	69,999.34	+267,9%
2025-12-22	Louie Ngar Yee	Director	Open Market Purchase	81,699	1.22	99,999.58	+382,8%
2025-12-22	CHAOUKI STEVEN M	Director	Open Market Purchase	40,849	1.22	49,999.18	+191,4%
2025-12-05	Smith Stan	Director	Open Market Purchase	4,580	1.20	5,496.00	+21,0%
2025-12-05	Smith Stan	Director	Open Market Purchase	4,580	1.20	5,494.63	+21,0%
2025-12-05	Smith Stan	Director	Open Market Purchase	4,580	1.19	5,450.20	+20,9%
2025-11-28	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	50,000	1.14	56,830.00	+217,5%
2025-11-28	Luput Cristian	Director	Open Market Purchase	18,145	1.11	20,229.86	+77,4%
2025-11-28	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	50,000	1.14	56,830.00	+217,5%
2025-11-26	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	22,000	1.05	23,018.60	+88,1%
2025-11-26	Luput Cristian	Director	Open Market Purchase	20,000	1.08	21,616.00	+82,7%
2025-11-26	Smith Stan	Director	Open Market Purchase	15,000	1.04	15,582.00	+59,6%
2025-11-26	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	22,000	1.05	23,018.60	+88,1%
2025-11-25	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	10,500	0.97	10,144.05	+38,8%
2025-11-25	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	10,500	0.97	10,144.05	+38,8%
2025-11-25	Luput Cristian	Director	Open Market Purchase	10,000	0.98	9,785.00	+37,5%
2025-11-25	Smith Stan	Director	Open Market Purchase	15,000	0.98	14,700.00	+56,3%
2025-11-24	Smith Stan	Director	Open Market Purchase	10,000	0.99	9,900.00	+37,9%
2025-11-24	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	10,000	0.99	9,891.00	+37,9%
2025-11-21	Vitoc Vlad	Director, Officer, 10% Owner, Chief Executive Officer	Open Market Purchase	1,800	0.92	1,656.00	+6,3%
2025-10-01	Smith Stan	Director	Open Market Purchase	19,230	1.30	24,999.00	+95,7%
2025-05-08	Guerrero Ramiro	Director	Open Market Purchase	20,000	1.50	30,000.00	+114,8%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.